A conjugate comprising a PBD dimer linked from the tether joining the two PBD units, wherein the linker is of formula (A1): (Formula (A1)) wherein R
N1
is selected from H and C
1-4
alkyl; L is a linker connected to a cell binding agent; CBA is the cell binding agent; n is an integer selected in the range of 0 to 48; Q is: (Formula (Q)), where Q
x
is such that Q is an amino-acid residue, a dipeptide residue or a tripeptide residue.
一个由连接两个PBD单元的纽带相连的PBD二聚体组成的共轭物,其中连接剂的结构式为(A1):(结构式(A1)) 其中R
N1
选自H和C
1-4
烷基;L是与细胞结合剂相连的连接剂;CBA是细胞结合剂;n是0到48范围内的整数;Q是:(结构式(Q)),其中Q
x
使得Q为氨基酸残基、二肽残基或三肽残基。
Sodium Tellurite as a Mild and Selective Oxidizing Agent for Thiols: Its Use in the One-Pot Synthesis of Unsymmetrical Disulfides
作者:Hitomi Suzuki、Sei-ichi Kawato、Akira Nasu
DOI:10.1246/bcsj.65.626
日期:1992.2
Sodium tellurite acts as a mild and highly selective oxidizingagent for thiols under phase-transfer conditions at room temperature. Aromatic and benzylic thiols are rapidly converted to disulfides. Short-chain primary thiols undergo oxidation in preference to long-chain thiols. Secondary thiols are sluggish in oxidation and tertiary thiols remain intact. No overoxidation of the sulfur atom is observed
Substituted o-Aminophenols as Redox-Mediators in the Thiol Oxidation to Unsymmetrical Disulfides
作者:Daria A. Burmistrova、Andrey Galustyan、Ivan V. Smolyaninov、Nadezhda T. Berberova
DOI:10.1149/1945-7111/abfe43
日期:2021.5.1
A number of substituted o-aminophenols has been investigated as redox mediators of the thiol oxidation to disulfides. The electrooxidation of o-aminophenols leads to the corresponding o-iminobenzoquinones. These compounds react with thiols in the solution with a formation of disulfides. It was established that the use of 4,6-di-tert-butyl-2-(tert-butylamino)phenol as a redox mediator can reduce the
[EN] AZASTEROIDS FOR TREATMENT OF TUBERCULOSIS<br/>[FR] COMPOSITION POUR LE TRAITEMENT DE LA TUBERCULOSE
申请人:UNIV NEW YORK STATE RES FOUND
公开号:WO2017190034A1
公开(公告)日:2017-11-02
The present invention provides a compound having the structure: formula (I), for use in combinatoin with an anti-tuberculosis drug for treating a subject infected with M. tuberculosis.
A conjugate of formula (A): Wherein Y is selected from formulae A1 and A2: Z1 is a C1-3 alkylene group; Z2 is a C1-3 alkylene group; Q is: where QX is such that Q is an amino-acid residue, a dipeptide residue or a tripeptide residue; L is a linker connected to a cell binding agent; CBA is the cell binding agent; and n is an integer between 0 and 48.